Recap Of Tuesday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Merck‘s (NYSE:MRK) lead asset MK-2060…
Synlogic Granted FDA Fast Track Designation For SYNB1353 For Treatment Of Homocystinuria (HCU)
CAMBRIDGE, Mass., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (NASDAQ:SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to
Why Ginkgo Bioworks Stock Is Soaring Today
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Thursday after Synlogic Inc (NASDAQ: SYBX) announced a new drug candidate for the treatment of gout, which is being developed in partne
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell
• Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers
Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.
Synlogic Granted U.S. Patent Titled ‘BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION (INCLUDING BUT NOT LIMITED TO CELIAC DISEASE, CROHN’S DISEASE, MULTIPLE SCLEROSIS)’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=11384359&OS=11384359&RS=11384359
Synlogic Initiates Phase 1 Study of SYNB1353 for the Treatment of Homocystinuria
Expected data in H2 2022 brings Synlogic to three clinical readouts this year
Third candidate in less than two years to enter the clinic; Reflects productivity of Synthetic Biotic platform
CAMBRIDGE, Mass., July
22 Stocks Moving in Thursday’s Pre-Market Session
Gainers
WISeKey International Holding AG (NASDAQ: WKEY) rose 74.4% to $2.32 in pre-market trading. WISeKey International recently issued 2022 first-half revenue guidance for its IoT segment.